Cambridge Healthtech Institute’s 4th Annual
Neoantigen Targeted Therapies
Personalized Cancer Immunotherapy in the Genomic Era
August 8-9, 2019
Fueled with advances in genomic technologies, personalized oncology promises to innovate cancer therapy and target previously undruggable space. Developments in NGS technology enabled systematic analysis of patient-specific mutanome and opens the door
to developing personalized cancer vaccines and other therapies targeting neoantigens. Cambridge Healthtech Institute’s Fourth Annual Neoantigen Targeted Therapies conference brings together thought leaders from pharmaceutical and biotech companies,
leading academic teams and clinical immuno-oncologists to share research and case studies in implementing patient-centric approaches to using the immune system to beat cancer, including utilizing NGS to identify tumor-specific neoantigens, using in silico tools to predict immunogenic neoepitopes, and targeting them with personalized vaccines, novel antibodies or combination therapies.
Cover will include, but is not limited to:
- Targeting patient-specific tumor neoepitopes
- Identification and prediction of tumor-specific neoantigens
- In silico prediction of immunogenic neoepitopes
- Personalized immunotherapy targeting NGS-identified neoantigens
- Therapeutic approaches for novel neoantigen targets
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is January 11, 2019.
All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
Email: juliab@healthtech.com
For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com